Skip to content
Life Sciences DNA Podcast cover art

All Episodes

Life Sciences DNA Podcast — 53 episodes

#
Title
1

Putting Business Value at the Center of AI in Biopharma

2

Turning Data and AI Into Better Business Outcomes

3

Measuring AI by Business Results in Life Sciences

4

Lessons from Insmed’s Journey to an AI First Biotech

5

Human Accountability in an Agentic Pharma World

6

Making AI Transformations that Stick

7

Finding ROI from AI in the Mundane

8

A Pragmatic Path to AI-Enabled Commercial Operations

9

Reimagining Scientific Work in the Age of AI Agents

10

Orchestrating Scientists, Data, and AI to Discover New Drugs

11

Scaling Practical AI Across Commercial Teams

12

Building an AI-Ready Biopharma Organization

13

Automating Biopharma Workflows with AI and Robotics

14

De-Risking Discovery and Improving the Success Rates of Drug Development with AI

15

Agents of Change: Creating Regulatory Documents with AI

16

Redefining Biomarkers for Immune-Mediated Disease with AI

17

Driving Insights from Real World Oncology Data with AI

18

Improving Drug Development with Real-World Data

19

Navigating the AI Landscape in Clinical Development

20

Transforming Cancer Diagnostics and Care with AI

21

Moving Beyond the Hype of AI in Biopharma

22

Why AI’s Most Promising Near-Term Value Is in Clinical Operations

23

Teaching the Biopharma Workforce to Coexist with AI

24

Making Clinical Trials More Predictable with AI

25

Finding Healthcare Providers from Clinical Trials to War Zones

26

Driving Efficiency in Drug Development with AI

27

Improving Clinical Trial Designs with AI

28

Improving the Efficiency of the Pharma Workforce with AI

29

Navigating AI Implementation in Pharma

30

Transforming Cancer Care in India with AI

31

Navigating the Challenges of Integrating AI in Clinical Development

32

Leveraging AI in Clinical Development

33

Integrating AI into Precision Medicine

34

Transforming Clinical Development with AI

35

Generating Proteins Nature Never Imagined

36

Why Data Strategy Must Be Tied to Business Outcomes

37

Biopharma Companies Wrestle with an Outsized Demand for AI Talent

38

Using AI and Synthetic Biology to Go Where Antibody Therapies Can’t

39

Unlocking Market Access with AI

40

Ensuring Successful Implementation of AI

41

Tackling the New Bottleneck of Drug Discovery

42

Swimming in the Deep End of AI

43

Using AI to Make Biology Easier to Engineer

44

How AI ls Reshaping the Future of Healthcare

45

A Venture Studio with Big Pharma Backing Seeks to Fix Drug Development with AI

46

Decoding the Immune System to Optimize Immunotherapies

47

Bringing Precision Medicine to Mental Health with AI

48

The Power and Peril of Generative AI in Biopharma and Healthcare

49

Unlocking the Complexity of Disease with Transomics and AI

50

Why Biopharma Companies Should Recognize Data Analytics and AI as Strategic Advantages

51

Making Undruggable Targets a Thing of the Past

52

Using AI to Revolutionize Precision Oncology

53

Leveraging Data Analytics to Enhance Biopharma Sales